Posted inBiotechnology
Imaging Single Extracellular Vesicles with RCA-Expansion
In a remarkable leap forward for cellular biology and nanotechnology, researchers have unveiled a pioneering technique to visualize single extracellular…
Posted inBiotechnology
AXL Inhibitor TP-0903 Induces Neuroblastoma Apoptosis
In a groundbreaking advance poised to reshape pediatric oncology, researchers have delineated the intricate molecular pathways through which a novel…
Posted inBiotechnology
Sarcocystis halieti DNA Found in Birds Across Europe
In a groundbreaking study that reshapes our understanding of avian parasitology, researchers have successfully detected the DNA of Sarcocystis halieti—a…
Posted inBiotechnology
Dynamic Surface Effects Boost CO2 Reduction Efficiency
Electrocatalytic CO2 reduction is swiftly emerging as a critical area in the fight against climate change and has gained significant…
Posted inBiotechnology
Study Finds Women with Down Syndrome May Experience Faster Progression of Alzheimer’s Disease Than Men
In a groundbreaking study published recently in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, researchers from the University…
Posted inResearch
Medidata elevates Amgen vet Moneymaker to lead business strategy
Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa Moneymaker will now guide…
Posted inBiotechnology
Chungnam National University Innovates Next-Gen Zinc Batteries with Artificial Polymer Nanolayers Enhancing Stability
Aqueous zinc-ion batteries (ZIBs) have rapidly emerged as a compelling alternative to the ubiquitous lithium-ion batteries (LIBs) fueling much of…
Posted inMedical Technology
Conformal Medical nets $32M to complete trial of foam-based heart occluder
Conformal Medical has raised $32 million to support the development of its heart implant designed to reduce the lifetime risk…
Posted inMedical Technology
Nyxoah plans US launch of sleep apnea implant, as rival Inspire lobs patent suit
After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now claimed an…
Posted inBiotechnology
VC firm Hatteras reels in $200M across 2 funds for early-stage life sciences investments
Hatteras Venture Partners has secured over $200 million across a pair of funds that are set to benefit up-and-coming biotechs…